Trial site
Atlanta
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Schizophrenia8 trials
- Depression3 trials
- Bipolar disorder2 trials
- Huntington's disease1 trial
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Recruiting7 trials
- Completed3 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Neurocrine Biosciences14 trials
- Neurocrine Switzerland GmbH1 trial
Running trials
Recruiting
Recruiting
Recruiting
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Recruiting
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Schizophrenia3 recruiting
- Depression2 recruiting
- Bipolar disorder1 recruiting
Closed trials
Recruiting
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Completed
Terminated
Terminated
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026